USA - engelsk - NLM (National Library of Medicine)

mayne pharma inc. - vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - vitamin a 1500 [iu] in 1 ml - supplementation of the diet with vitamins a, c, d and fluoride 0.25 mg drops also provides fluoride for caries prophylaxis. the american academy of pediatrics recommends that children up to age 16, in areas where drinking water contains less than optimal levels of fluoride, receive daily fluoride supplementation. vitamins a, c, d and fluoride 0.25 mg drops provide fluoride in drop form for infants and young children 6 months to 3 years of age, in areas where the drinking water contains children ages 2-3 years where the drinking water contains less than 0.3 ppm of fluoride and for children over 3 years, in areas where the drinking water contains 0.3 through 0.7 ppm of fluoride. each 1.0 ml provides sodium fluoride (0.25 mg fluoride) plus eight essential vitamins and iron. the american academy of pediatrics recommends that infants and young children under 6 months to 3 years of age, in areas where drinking water contains less than 0.3 ppm of fluoride, and; and for children ages 3-6 years, in areas where the dri

Canada - engelsk - Health Canada

quest vitamins a div of purity life health products - vitamin a (retinol palmitate); vitamin d - capsule - 10000unit; 400unit - vitamin a (retinol palmitate) 10000unit; vitamin d 400unit - vitamin a and d

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - nicotinamide; pyridoxine hydrochloride; riboflavin; thiamine hydrochloride - oral tablet - 20mg ; 2mg ; 2mg ; 5mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

br pharmaceuticals ltd - nicotinamide; riboflavin; thiamine hydrochloride - oral tablet - 15mg ; 1mg ; 1mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - nicotinamide; riboflavin; thiamine hydrochloride - oral tablet - 15mg ; 1mg ; 1mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - nicotinamide; riboflavin; thiamine hydrochloride - oral tablet - 15mg ; 1mg ; 1mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

almus pharmaceuticals ltd - nicotinamide; riboflavin; thiamine hydrochloride - oral tablet - 15mg ; 1mg ; 1mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - nicotinamide; pyridoxine hydrochloride; riboflavin; thiamine hydrochloride - oral tablet - 20mg ; 2mg ; 2mg ; 5mg

Den europeiske union - gresk - EMA (European Medicines Agency)

gilead sciences international ltd - elvitegravir - hiv Λοιμώξεις - Αντιιικά για συστηματική χρήση - vitekta συγχορηγείται με ένα αναστολέα πρωτεάσης ριτοναβίρη-ενισχύθηκε και με άλλους αντιρετροϊκούς παράγοντες, είναι υποδειγμένο για τη θεραπεία του ανθρώπου-ανοσοανεπάρκειας-ιού-1 (hiv-1) μόλυνση στους ενήλικες που έχουν μολυνθεί με τον ιό hiv-1 χωρίς γνωστές μεταλλάξεις που σχετίζεται με αντίσταση στην elvitegravir.

Den europeiske union - maltesisk - EMA (European Medicines Agency)

gilead sciences international ltd - elvitegravir - infezzjonijiet ta 'hiv - antivirali għal użu sistemiku - vitekta ko amministrati bl-inibitur protease qawwa ritonavir u ma ' l-aġenti l-oħra antiretroviral, huwa indikat għall-kura ta ' l-infezzjoni (hiv-1) umani-immunodefiċjenza-virus-1 fl-adulti li huma infettati bl-hiv-1 mingħajr mutazzjonijiet magħrufa assoċjati ma ' reżistenza għall-elvitegravir.